bluebird bio (BLUE) Tops Q4 EPS by 76c, Updates on BLA Submission for Lovo-Cel for Sickle Cell Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to bluebird bio (BLUE) Tops Q4 EPS by 76c, Updates on BLA Submission for Lovo-Cel for Sickle Cell Disease

bluebird bio (BLUE) Halted on Volatility, Down 26%

March 29, 2023 9:33 AM EDT

bluebird bio (NASDAQ: BLUE) Halted on Volatility, Down 26%

... More

bluebird bio (BLUE) Declines Following Update on Sickle Cell Drug Application

March 29, 2023 8:29 AM EDT

bluebird bio (NASDAQ: BLUE) Declines Following Update on Sickle Cell Drug Application

Earlier company said BLA submission anticipated following response from FDA on analytical comparability data in the coming weeks for Lovo-cel. Company had set a goal by the end of March for sickle cell drug.Shares down 11% pre-open.... More